Los Angeles, CA, United States of America

Mariana Carla Stern

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2019-2021

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Mariana Carla Stern

Introduction

Mariana Carla Stern is a prominent inventor based in Los Angeles, CA. She has made significant contributions to the field of cancer research, particularly in the area of prostate cancer prognosis. With a total of 2 patents, her work focuses on developing gene expression panels that aid in predicting cancer progression.

Latest Patents

One of her latest patents is a gene expression panel for the prognosis of prostate cancer recurrence. This invention provides methods for predicting clinical recurrence of prostate cancer (PCa). The panel includes a collection of signature genes, such as NKX2-1, which are analyzed to assess the risk of prostate cancer-related mortality. Another patent also revolves around a gene expression panel for predicting the progression of prostate cancer in individuals. This method involves receiving expression levels of signature genes from biological samples and applying these levels to a predictive model to evaluate cancer progression.

Career Highlights

Mariana has worked with notable organizations, including Illumina Corporation and the University of Southern California. Her experience in these institutions has allowed her to collaborate with leading experts in the field of cancer research.

Collaborations

Some of her notable coworkers include Jacek K Pinski and Jian-Bing Fan. Their collaborative efforts have contributed to advancements in understanding prostate cancer and improving patient outcomes.

Conclusion

Mariana Carla Stern's innovative work in developing gene expression panels for prostate cancer prognosis showcases her dedication to advancing medical research. Her contributions are vital in the ongoing fight against cancer, and her patents reflect her commitment to improving patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…